Message
FDA seeks strong warning for MRI contrast agents
23.05.07
WASHINGTON (MarketWatch)—The Food and Drug Administration said Wednesday it is asking manufacturers of certain contrast agents used in patients undergoing magnetic resonance imaging, or MRI scans, to place a black-box warning on the agents’ packaging.
http://www.antidrug.health.am/news/healthandlaw/posts/2891/